Clinical Trial Update: Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating pirfenidone in pulmonary fibrosis with anti-myeloperoxidase antibodies has completed. The update notes the trial status without d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• Pirfenidone (Esbriet) (pirfenidone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pulmonary Fibrosis | Phase 2 | Status: COMPLETED